<DOC>
	<DOCNO>NCT02283879</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy human umbilical cord mesenchymal stem cell ( hUC-MSC ) cerebral hemorrhage sequela .</brief_summary>
	<brief_title>Human Umbilical Cord Mesenchymal Stem Cell Cerebral Hemorrhage Sequela</brief_title>
	<detailed_description>Human umbilical cord mesenchymal stem cell exhibit potential differentiate neural cell , confirm vivo vitro experiment . There clinical report describe umbilical cord mesenchymal stem cell treatment cerebral hemorrhage . To investigate effect hUC-MSC treatment cerebral hemorrhage sequela , 20 patient cerebral hemorrhage enrol receive 4 time hUC-MSC transplantation .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<criteria>Aged 4070 intracerebral hemorrhage patient With stroke history 3 month , less 60 month National Institutes Health stroke scale ( NIHSS ) score 7 point Patient stable ( normal respiration , afebrile , BP le mean arterial pressure 125 mm Hg , fast blood sugar &lt; 7 mg , normal urea/electrolytes least 48 hour . ) History neurological disease , head injury psychiatric disorder ; Pregnant woman ; Impaired liver function , abnormal blood coagulation , AIDS , HIV , combine tumor special condition ; Progressive apoplexy ; With malignant tumor .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Human Umbilical Cord Mesenchymal Stem Cell</keyword>
	<keyword>Mesenchymal Stem Cell</keyword>
	<keyword>Cerebral hemorrhage</keyword>
</DOC>